FDA Requests Belviq Be Pulled From The US Market Due To Cancer Risk

13:43 EST 13 Feb 2020 | SCRIP

The agency requested the weight loss pill be voluntarily recalled by Eisai, the death knell for a trio of obesity...

Original Article: FDA Requests Belviq Be Pulled From The US Market Due To Cancer Risk

More From BioPortfolio on "FDA Requests Belviq Be Pulled From The US Market Due To Cancer Risk"